191 related articles for article (PubMed ID: 36933449)
1. Novel evidence of Thymosin α1 immunomodulatory properties in SARS-CoV-2 infection: Effect on innate inflammatory response in a peripheral blood mononuclear cell-based in vitro model.
Ricci D; Etna MP; Severa M; Fiore S; Rizzo F; Iannetta M; Andreoni M; Balducci S; Stefanelli P; Palamara AT; Coccia EM
Int Immunopharmacol; 2023 Apr; 117():109996. PubMed ID: 36933449
[TBL] [Abstract][Full Text] [Related]
2. Thymosin α1 modulated the immune landscape of COVID-19 patients revealed by single-cell RNA and TCR sequencing.
Bai H; Liang L; Qi X; Xu Y; Liu Y; Ren D; Cai Z; Mao W; Wang X; Qin H; Hu F; Shi B
Int Immunopharmacol; 2023 Nov; 124(Pt B):110983. PubMed ID: 37769533
[TBL] [Abstract][Full Text] [Related]
3. Thymosin alpha 1 restores the immune homeostasis in lymphocytes during Post-Acute sequelae of SARS-CoV-2 infection.
Minutolo A; Petrone V; Fanelli M; Maracchioni C; Giudice M; Teti E; Coppola L; Sorace C; Iannetta M; Tony Miele M; Bernardini S; Mastino A; Sinibaldi Vallebona P; Balestrieri E; Andreoni M; Sarmati L; Grelli S; Garaci E; Matteucci C
Int Immunopharmacol; 2023 May; 118():110055. PubMed ID: 36989892
[TBL] [Abstract][Full Text] [Related]
4. Dual effect of Thymosin α 1 on human monocyte-derived dendritic cell in vitro stimulated with viral and bacterial toll-like receptor agonists.
Giacomini E; Severa M; Cruciani M; Etna MP; Rizzo F; Pardini M; Scagnolari C; Garaci E; Coccia EM
Expert Opin Biol Ther; 2015; 15 Suppl 1():S59-70. PubMed ID: 26096650
[TBL] [Abstract][Full Text] [Related]
5. Thymosin Alpha 1 Reduces the Mortality of Severe Coronavirus Disease 2019 by Restoration of Lymphocytopenia and Reversion of Exhausted T Cells.
Liu Y; Pan Y; Hu Z; Wu M; Wang C; Feng Z; Mao C; Tan Y; Liu Y; Chen L; Li M; Wang G; Yuan Z; Diao B; Wu Y; Chen Y
Clin Infect Dis; 2020 Nov; 71(16):2150-2157. PubMed ID: 32442287
[TBL] [Abstract][Full Text] [Related]
6. Thymosin alpha 1 - Reimagine its broader applications in the immuno-oncology era.
Mao L
Int Immunopharmacol; 2023 Apr; 117():109952. PubMed ID: 36871535
[TBL] [Abstract][Full Text] [Related]
7. Thymosin-α1 expands deficient IL-10-producing regulatory B cell subsets in relapsing-remitting multiple sclerosis patients.
Giacomini E; Rizzo F; Etna MP; Cruciani M; Mechelli R; Buscarinu MC; Pica F; D'Agostini C; Salvetti M; Coccia EM; Severa M
Mult Scler; 2018 Feb; 24(2):127-139. PubMed ID: 28273784
[TBL] [Abstract][Full Text] [Related]
8. Gender-associated difference following COVID-19 virus infection: Implications for thymosin alpha-1 therapy.
Li X; Liu L; Yang Y; Yang X; Wang C; Li Y; Ge Y; Shi Y; Lv P; Zhou H; Luo P; Huang S
Int Immunopharmacol; 2021 Jan; 90():107022. PubMed ID: 33160854
[TBL] [Abstract][Full Text] [Related]
9. [The anti-tumor efforts of thymosin alpha1 on tumor lysate-pulsed dendritic cells in colon cancer in vitro and in vivo].
Ma YL; Zheng Z; Li BD; Xie SJ; Li GX; Yan QH; Cai JH
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Nov; 23(11):1046-9. PubMed ID: 17988589
[TBL] [Abstract][Full Text] [Related]
10. In vitro effect of thymosin-alpha1 and interferon-alpha on Th1 and Th2 cytokine synthesis in patients with eAg-negative chronic hepatitis B.
Loggi E; Gramenzi A; Margotti M; Cursaro C; Galli S; Vitale G; Grandini E; Scuteri A; Vukotic R; Andreone P; Bernardi M
J Viral Hepat; 2008 Jun; 15(6):442-8. PubMed ID: 18221304
[TBL] [Abstract][Full Text] [Related]
11. Thymosin-alpha1 modulates dendritic cell differentiation and functional maturation from human peripheral blood CD14+ monocytes.
Yao Q; Doan LX; Zhang R; Bharadwaj U; Li M; Chen C
Immunol Lett; 2007 Jun; 110(2):110-20. PubMed ID: 17532057
[TBL] [Abstract][Full Text] [Related]
12. Induction of Exaggerated Cytokine Production in Human Peripheral Blood Mononuclear Cells by a Recombinant SARS-CoV-2 Spike Glycoprotein S1 and Its Inhibition by Dexamethasone.
Olajide OA; Iwuanyanwu VU; Lepiarz-Raba I; Al-Hindawi AA
Inflammation; 2021 Oct; 44(5):1865-1877. PubMed ID: 33860869
[TBL] [Abstract][Full Text] [Related]
13. Thymosin Alpha-1 Has no Beneficial Effect on Restoring CD4+ and CD8+ T Lymphocyte Counts in COVID-19 Patients.
Wang Z; Chen J; Zhu C; Liu L; Qi T; Shen Y; Zhang Y; Xu L; Li T; Qian Z; Steinhart CR; Lu H
Front Immunol; 2021; 12():568789. PubMed ID: 34149679
[TBL] [Abstract][Full Text] [Related]
14. Immune modulation via dendritic cells by the effect of Thymosin-alpha-1 on immune synapse in HCMV infection.
Espinar-Buitrago MS; Vazquez-Alejo E; Magro-Lopez E; Tarancon-Diez L; Leal M; Muñoz-Fernandez MA
Int Immunopharmacol; 2023 Dec; 125(Pt A):111103. PubMed ID: 38149577
[TBL] [Abstract][Full Text] [Related]
15. Mast cells activated by SARS-CoV-2 release histamine which increases IL-1 levels causing cytokine storm and inflammatory reaction in COVID-19.
Conti P; Caraffa A; Tetè G; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Di Emidio P; Ronconi G
J Biol Regul Homeost Agents; 2020 Sep-Oct,; 34(5):1629-1632. PubMed ID: 32945158
[TBL] [Abstract][Full Text] [Related]
16. Effect of thymosin alpha-1 on subpopulations of Th1, Th2, Th17, and regulatory T cells (Tregs) in vitro.
Yang X; Qian F; He HY; Liu KJ; Lan YZ; Ni B; Tian Y; Fu XL; Zhang J; Shen ZG; Li J; Yin Y; Li JT; Wu YZ
Braz J Med Biol Res; 2012 Jan; 45(1):25-32. PubMed ID: 22245858
[TBL] [Abstract][Full Text] [Related]
17. Thymosin α1 and Its Role in Viral Infectious Diseases: The Mechanism and Clinical Application.
Tao N; Xu X; Ying Y; Hu S; Sun Q; Lv G; Gao J
Molecules; 2023 Apr; 28(8):. PubMed ID: 37110771
[TBL] [Abstract][Full Text] [Related]
18. PM10 promotes an inflammatory cytokine response that may impact SARS-CoV-2 replication
Marín-Palma D; Tabares-Guevara JH; Zapata-Cardona MI; Zapata-Builes W; Taborda N; Rugeles MT; Hernandez JC
Front Immunol; 2023; 14():1161135. PubMed ID: 37180105
[TBL] [Abstract][Full Text] [Related]
19. Targeting Doublecortin-Like Kinase 1 (DCLK1)-Regulated SARS-CoV-2 Pathogenesis in COVID-19.
Undi RB; Larabee JL; Filiberti A; Ulahannan S; Aravindan S; Stroberg E; Barton LM; Duval EJ; Mukhopadhyay S; Henthorn JC; Akins D; Houchen CW; Huycke MM; Ali N
J Virol; 2022 Sep; 96(17):e0096722. PubMed ID: 35943255
[TBL] [Abstract][Full Text] [Related]
20. Enhanced Immunomodulatory Effects of Thymosin-Alpha-1 in Combination with Polyanionic Carbosilane Dendrimers against HCMV Infection.
Espinar-Buitrago MS; Magro-López E; Vázquez-Alejo E; Muñoz-Fernández MÁ
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
